Request Demo
Last update 28 Feb 2026
Anti -CD19 UCAR-NK cells(Chongqing Precision Biotech)
Last update 28 Feb 2026
Overview
Basic Info
Drug Type CAR-NK |
Synonyms UCAR-NK |
Target |
Action inhibitors |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Anti -CD19 UCAR-NK cells(Chongqing Precision Biotech)NCT05570188
An Investigator-initiated Trial Evaluating the Efficacy and Safety of Anti-CD19 Universal CAR-NK(U-CAR-NK) Cells Therapy Combined With Hematopoietic Stem Cell Transplantation(HSCT) for B Cell Hematologic Malignancies
NCT04639739
Anti-CD19 CAR NK Cell Therapy for Relapsed or Refractory B Cell Non-Hodgkin Lymphoma: a Multi-center, Uncontrolled Trial.
100 Clinical Results associated with Anti -CD19 UCAR-NK cells(Chongqing Precision Biotech)
Login to view more data
100 Translational Medicine associated with Anti -CD19 UCAR-NK cells(Chongqing Precision Biotech)
Login to view more data
100 Patents (Medical) associated with Anti -CD19 UCAR-NK cells(Chongqing Precision Biotech)
Login to view more data
100 Deals associated with Anti -CD19 UCAR-NK cells(Chongqing Precision Biotech)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-Cell Leukemia | Phase 2 | China | 01 Oct 2022 | |
| B-Cell Lymphoma | Phase 2 | China | 01 Oct 2022 | |
| B-cell lymphoma refractory | Phase 1 | China | 17 Dec 2020 | |
| Acute Myeloid Leukemia | Preclinical | China | 22 Aug 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free